These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31903178)

  • 21. Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial.
    Sattarinezhad A; Roozbeh J; Shirazi Yeganeh B; Omrani GR; Shams M
    Diabetes Metab; 2019 Jan; 45(1):53-59. PubMed ID: 29983230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes: A Secondary Analysis of a Randomized Trial.
    Kim SH; Brodsky IG; Chatterjee R; Kashyap SR; Knowler WC; Liao E; Nelson J; Pratley R; Rasouli N; Vickery EM; Sarnak M; Pittas AG; ;
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1201-1209. PubMed ID: 34362787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney Function Improvement by Soy Milk Containing Lactobacillus plantarum A7 in Type 2 Diabetic Patients With Nephropathy: a Double-Blinded Randomized Controlled Trial.
    Abbasi B; Ghiasvand R; Mirlohi M
    Iran J Kidney Dis; 2017 Jan; 11(1):36-43. PubMed ID: 28174351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Expression of Circulating Stress Markers, Inflammatory Cytokines and Decreased Antioxidant Level in Diabetic Nephropathy.
    Mansoor G; Tahir M; Maqbool T; Abbasi SQ; Hadi F; Shakoori TA; Akhtar S; Rafiq M; Ashraf M; Ullah I
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363561
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function.
    Petrykiv S; Sjöström CD; Greasley PJ; Xu J; Persson F; Heerspink HJL
    Clin J Am Soc Nephrol; 2017 May; 12(5):751-759. PubMed ID: 28302903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria: A Randomized, Controlled Trial.
    Ito S; Kagawa T; Saiki T; Shimizu K; Kuroda S; Sano Y; Umeda Y
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):354-363. PubMed ID: 30755452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium Bicarbonate Supplementation and Urinary TGF-
    Raphael KL; Greene T; Wei G; Bullshoe T; Tuttle K; Cheung AK; Beddhu S
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):200-208. PubMed ID: 31974286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
    Bursell SE; Clermont AC; Aiello LP; Aiello LM; Schlossman DK; Feener EP; Laffel L; King GL
    Diabetes Care; 1999 Aug; 22(8):1245-51. PubMed ID: 10480765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D and Hypoxia-Inducible Factor (HIF-1α) Serum Levels as Markers for Progression of Nephropathy in Type 2 Diabetic Patients.
    Gharib AF; Askary AE; Almehmadi M; Etewa RL; Althobaiti BB; Allam HH; Elsayyad LK; Shafie A
    Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-term vitamin D and n-3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: secondary analyses from a randomised controlled trial.
    Limonte CP; Zelnick LR; Ruzinski J; Hoofnagle AN; Thadhani R; Melamed ML; Lee IM; Buring JE; Sesso HD; Manson JE; de Boer IH
    Diabetologia; 2021 Feb; 64(2):437-447. PubMed ID: 33098434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients.
    Jain SK; Krueger KS; McVie R; Jaramillo JJ; Palmer M; Smith T
    Diabetes Care; 1998 Sep; 21(9):1511-6. PubMed ID: 9727900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Stratification of Diabetic Kidney Disease Using Serum Cystatin C and Serum Creatinine Based Estimating Equations in Type 2 Diabetes: A Comparative Analysis.
    Avinash S; Singh VP; Agarwal AK; Chatterjee S; Araya V
    J Assoc Physicians India; 2015 Nov; 63(11):28-35. PubMed ID: 29900708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of 12 weeks carnosine supplementation on renal functional integrity and oxidative stress in pediatric patients with diabetic nephropathy: a randomized placebo-controlled trial.
    Elbarbary NS; Ismail EAR; El-Naggar AR; Hamouda MH; El-Hamamsy M
    Pediatr Diabetes; 2018 May; 19(3):470-477. PubMed ID: 28744992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
    Joergensen C; Tarnow L; Goetze JP; Rossing P
    Diabet Med; 2015 Mar; 32(3):374-81. PubMed ID: 25307511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study.
    Han SY; Yoon SA; Han BG; Kim SG; Jo YI; Jeong KH; Oh KH; Park HC; Park SH; Kang SW; Na KR; Kang SW; Kim NH; Jang Y; Kim B; Shin S; Cha DR
    Diabetes Obes Metab; 2018 Feb; 20(2):292-300. PubMed ID: 28719008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway.
    Kuhad A; Chopra K
    Life Sci; 2009 Feb; 84(9-10):296-301. PubMed ID: 19162042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D Supplementation Could Enhance the Effectiveness of Glibenclamide in Treating Diabetes and Preventing Diabetic Nephropathy: A Biochemical, Histological and Immunohistochemical Study.
    Atia T; Iqbal MZ; Fathy Ahmed H; Sakr HI; Abdelzaher MH; Morsi DF; Metawee ME
    J Evid Based Integr Med; 2022; 27():2515690X221116403. PubMed ID: 35942573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of vitamin D
    Esfandiari A; Pourghassem Gargari B; Noshad H; Sarbakhsh P; Mobasseri M; Barzegari M; Arzhang P
    Diabetes Metab Syndr; 2019; 13(1):278-283. PubMed ID: 30641712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.